Metastasizing aneurysmal dermatofibroma initially diagnosed as angiosarcoma confirmed by CD63::PRKCD fusion gene detection with nanopore sequencing
Naoki Takeda,Naohiro Makise,Jason Lin,Hajime Kageyama,Mariko Oikawa,Takahiro Sugiyama,Hidetada Kawana,Akinobu Araki,Toshinori Tuskanishi,Hideyuki Kinoshita,Yoko Hagiwara,Hiroto Kamoda,Toru Motoi,Tsukasa Yonemoto,Masahito Kawazu,Makiko Itami
DOI: https://doi.org/10.1002/gcc.23246
2024-05-17
Genes Chromosomes and Cancer
Abstract:Dermatofibroma (DF) is a benign tumor that forms pedunculated lesions ranging in size from a few millimeters to 2 cm, usually affecting the extremities and trunks of young adults. Histopathologically, DF is characterized by the storiform proliferation of monomorphic fibroblast‐like spindle cells. In addition to neoplastic cells, secondary elements such as foamy histiocytes, Touton‐type giant cells, lymphoplasmacytes, and epidermal hyperplasia are characteristic histological features. Several histological variants, including atypical, cellular, aneurysmal, and lipidized variants, have been reported; cases with variant histologies are sometimes misdiagnosed as sarcomas. We present a case of metastasizing aneurysmal DF that was initially diagnosed as an angiosarcoma on biopsy. A 26‐year‐old woman was referred to our hospital with a gradually enlarging subcutaneous mass in her lower left leg. Positron emission tomography‐computed tomography revealed high fluorodeoxyglucose uptake not only in the tumor but also in the left inguinal region. On biopsy, ERG and CD31‐positive atypical spindle cells proliferated in slit‐like spaces with extravasation, leading to the diagnosis of angiosarcoma. Histology of the wide‐resection specimen was consistent with DF, and lymph node metastasis was also observed. Nanopore DNA sequencing detected CD63::PRKCD fusion and copy number gain, although CD63 was not included in the target region of adaptive sampling. This report highlights the importance of recognizing the unusual clinical, radiological, and pathological features of DF to avoid misdiagnosis, and the potential diagnostic utility of nanopore sequencer.
oncology,genetics & heredity